Helpline 07939 046 030
Freephone 0300 102 17 22*

Shine A Light On NF! We work with organisations worldwide to light up landmarks and buildings blue for May 17, World NF Awareness Day.

Donate here

Help us Shine A Light on World NF Awareness Day, Sunday 17 May 2026, as we highlight and campaign for access to the medical and non-medical care that is needed by those diagnosed with NF in the UK.

In collaboration with Children’s Tumor Foundation USA, the 'Shine A Light On NF' campaign aims to raise awareness by lighting up iconic landmarks, buildings and homes in blue.

NF is the medical group name for Neurofibromatosis Type 1 (NF1), NF2-related-Schwannomatosis (NF2-SWN) and Schwannomatosis (SWN), a set of neuro-genetic conditions that cause tumours to grow on nerve endings, and which also have many associated medical conditions and complications.

As NF is still a relatively unknown condition, our attempts to raise awareness are greatly valued by the NF community - seeing buildings light up locally, nationally and internationally shows the community that they are being seen and heard.

We provide Social Media Toolkits to all willing organisations to showcase why they are lighting up, along with information and donation links, and other ways to support people with NF.

Find out how you can help our campaign here

A special relationship

Nerve Tumours UK is taking part in the 11th 'Shine A Light On NF' awareness campaign with Children's Tumor Foundation, emphasising our commitment to supporting and advocating for the NF community, and making NF visible.

"We were very happy to have contributed, with over 400 landmarks lighting up worldwide last year, including USA, Canada, Australia, China, Italy, Thailand & Singapore, and we want to do even better this year. 176 of those light ups were in the UK & Republic of Ireland, we keep going to support our NF Community."

– Alison Lobo, Community Fundraising & Campaigns Coordinator at Nerve Tumours UK

Take a look at some of the buildings and landmarks already signed up for 2026.

Alexandra Palace Mast, London; Bascule Bridge, Renfrewshire; Bottle of Notes, North Yorkshire; Bridgewater Hall, Greater Manchester; Cardiff Castle; Carmarthen County Hall; Chichester Council House, West Sussex; County Hall, Somerset; Derbion Shopping Centre, Derbyshire; Enniskillen Castle, County Fermanagah; Epsom Downs Race Course Queen Elizabeth II Stand, Surrey; Hamilton Town House, Lanarkshire; Holywell Town Council, Flintshire; Marischal College, Aberdeenshire; Maritime Museum, East Yorkshire; Meadowhall, South Yorkshire; Mercury Theatre, Essex; New Theatre, Oxfordshire; Ness Bridge, Highlands; Newry Town Hall, County Down; Nottingham Council House; Paddington Station, London; Pershore Abbey, Worcestershire; Port of Liverpool Building, Merseyside; Queens Hotel, Gloucestershire, Quilter Head Office, Hampshire; Rochester Cathedral, Kent; St Andrew's House, Midlothian; St Ives Bridge and Chapel, Cambridgeshire; St James Church, Lincolnshire; Smeaton's Tower, Devon; Sir John Barrow Monument, Cumbria; St Andrew's House, Midlothian; Trowbridge Civic Centre, Wiltshire; Twin Sails Bridge, Dorset; Wainhouse Tower, West Yorkshire; Whittle Arch, West Midlands
 

NEW for 2026!

Albert Clock Tower, Barnstaple; Castle Point Borough Council Building, Essex; Chantry Place, Norwich; De La Warr Pavilion, East Sussex; Mercury Theatre, Essex; Paddington Station, London; Union Mill, Kent; University of Leicester (George Davies Centre); University of Liverpool School of Engineering; Wallasey Town Hall, Merseyside; Weymouth Pavilion, Dorset; Wigan Town Hall, Greater Manchester

Check out our map

showing all the buildings & landmarks lighting up in the UK for World NF Awareness

Click here to see the Shine A Light on NF 2026 light ups

"The amount of people who asked us what it was for and had to admit this was a health condition not heard of before was surprising, but it certainly got the message to a lot of people and I hope the same can be said in other areas of the country too."

– Elizabeth, Jarrold, Norwich

Join us in 2026

World NF Awareness Day, 17 May, & World NF2 Awareness Day, 22 May 

Can you help?

Support our campaign by copying and pasting the following text to your social media, emailing your local MP, local press, or anyone you can think of that will support our campaign.

Shine A Light on NF: Help raise awareness of NF by lighting up landmarks and buildings blue on World NF Awareness Day - Sunday 17 May. With 26,500 people in the UK diagnosed with NF, we want all of them to receive the care and support they need to live their lives. Find out more: https://nervetumours.org.uk/get-involved/shine-a-light-on-neurofibromatosis.

We are very grateful for all support, and donations can be made on the following link. https://www.justgiving.com/campaign/shine-a-light-on-nf

Information about the condition and our services

The Neurofibromatosis Association, trading as Nerve Tumours UK, funds a unique Specialist Support Network to help the 26,500 plus children and adults, living in the UK, who are diagnosed with NF, the medical group name for Neurofibromatosis Type 1 (NF1), NF2-related-Schwannomatosis (NF2) and Schwannomatosis (SWN), along with their carers, families, and their wider support network. For every patient we help, we estimate that we also help 8 further members of their network, so our reach stretches to supporting circa 212,000 people.

NF is one of the most common neuro-genetic conditions that causes tumours to grow on nerve endings and has many associated medical, physical and psychological conditions eg Scoliosis, 60% have learning disabilities, and up to 70% are registered disabled. People live in constant pain, are vulnerable and often isolated, and as this is a life-long genetic condition, it impacts hugely on their mental health. Parents have a 50% chance of passing this genetic condition onto their child, and once there are three generations of the family with the condition, research shows that they will fall into the lowest socio-economic group.

We provide our much needed support, advice and information for people with NF and the medical professionals involved in their care, via our Specialist Support Network, which comprises regionally based nurses, a national helpline, a fully accessible and interactive website incorporating a closed medical section, clinical guidelines, regional information days, medical guidelines and leaflets. We also support and collaborate in research with leading medics, UK universities and associated international bodies, although we are not in a position to fund the research.

We do not receive any government or local authority funding, we rely totally on donations and fundraising.

Masterclasses in NF: Ophthalmologic Findings & Orthopic Eye Examination in NF1 and NF2-Related Schwannomatosis

Ophthalmologic Findings & Orthopic Eye Examination in NF1 and NF2-Related Schwannomatosis

Prof. Dr. Berthold Pemp

OT Sabine Koinig

Masterclasses in NF: Plexiform Neurofibromas in NF1 - General Course and Neuroradiology

Plexiform Neurofibromas in NF1 - General Course and Neuroradiology

Assoc. Prof. Dr. Gregor Kasprian

Dr. Hector Salvador, MD

Masterclasses in NF: The Patients’ Perspective: A Masterclass on NF Care Held by NF Patients

Masterclasses in NF: Treatment Strategies for Vestibular Schwannomas: When to Treat? How to Treat?

Treatment Strategies for Vestibular Schwannomas: When to Treat? How to Treat?

 

Michel Kalamarides MD

Masterclasses in NF: Management Of Plexiform Neurofibromatosis in NF1- Rianne Oosterbrink, Justus L Groen, Karine Lascelles

Masterclasses in NF1: 1.Management Of Plexiform Neurofibromatosis in NF1

Rianne Oosterbrink MD

Justus L Groen MD

Karine Lascelles MD

Masterclasses in NF: Constitutional Mismatch Repair Deficiency Syndrome as Differential Diagnosis to NF1/Legius Syndrome - Prof. Dr. Katharina Wimmer

Constitutional Mismatch Repair Deficiency Syndrome as Differential Diagnosis to NF1/Legius Syndrome

Prof. Dr. Katharina Wimmer, Medical University of Innsbruck

Masterclasses in NF: Rare NF1-Associated Tumors in Adults - Eric Legius & Prof. Ellen Denayer

Masterclasses in NF: Rare NF1-Associated Tumors in Adults

Eric Legius, MD, PhD, University Hospital Leuven

Prof. Ellen Denayer, University Hospital Leuven

Masterclasses in NF: Optimising Hearing Outcomes in NF2-Related Schwannomatosis - Simon Freeman

Masterclasses in NF: Optimising Hearing Outcomes in NF2-Related Schwannomatosis

Simon Freeman, MPhil FRCS, Manchester Royal Infirmary and Salford Royal Hospital

Masterclasses in NF: NF1 Dermatological Manifestations - Pierre Wolkenstein, Laura Fertitta & Sirkku Peltonen

Masterclasses in NF: NF1 Dermatological Manifestations

Pierre Wolkenstein, MD, PhD, Hopital Henri-Mondor, Paris, France

Laura Fertitta, MD, Hôpital Universitaire Henri Mondor

Sirkku Peltonen, MD, PhD, University of Gothenberg, Sweden

Masterclasses in NF: Breast Cancer in NF1 - Gareth Evans

Masterclasses in NF: Breast Cancer in NF1

Gareth Evans, MD, University of Manchester, UK

Masterclasses in NF: Pain in Non-NF2-Related Schwannomatosis - David Pang

Masterclasses in NF: Pain in Non-NF2-Related Schwannomatosis

David Pang, MD, ChB. Guys and St Thomas' Hospital NHS Trust, London

Masterclasses in NF: Distinguishing Non-NF2-Related from NF2-Related Schwannomatosis - Clinical and Genetic Approaches - Said Farschtschi

Masterclasses in NF: Distinguishing Non-NF2-Related from NF2-Related Schwannomatosis - Clinical and Genetic Approaches

Said Farschtschi, MD, University Medical Center, Hamburg-Eppendorf, Germany

Masterclasses in NF: NF1 Pre-Implantation Genetic Diagnosis - Eric Legius & Prof. Ellen Denayer

Masterclasses in NF: NF1 Pre-Implantation Genetic Diagnosis

Eric Legius, MD, PHD, University Hospital of Leuven, Belgium

Prof. Ellen Denayer, University Hospital of Leuven, Belgium

NF2 Working Together: from a tentative diagnosis and beyond

Understanding the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

NF1 Working Together Part 2: from a tentative diagnosis and beyond

Understanding the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

NF1 Working Together Part 1: from a tentative diagnosis and beyond

Understanding  the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

Masterclasses in NF: Surgery in NF2 - Michel Kalamarides & Andrew King

Masterclasses in NF: Surgery in NF2

Michel Kalamarides, MD, PhD, Hôpital Pitié-Salpêtrière, Paris, France

Prof Andrew King, MBBS FRCS FRCS(SN), Salford Royal Hospital, Manchester, United Kingdom. Member of the MAB of Nerve Tumours UK

Masterclasses in NF: Cognition and Behaviour in NF1: Phenotype and Treatment Approaches - Shruti Garg, Andre Rietman

Masterclasses in NF: Cognition and Behaviour in NF1: Phenotype and Treatment Approaches

Dr Shruti Garg, MBBS, MRCPsych, MMedSci, PhD, Royal Manchester Children’s Hospital, United Kingdom. Member of the MAB of Nerve Tumours UK

Andre Rietman, PhD, Erasmus University Medical Center, Rotterdam, Netherlands

Masterclasses in NF: Emotional Challenges in NF1, NF2 and Schwannomatosis - Susie Henley, Thomas Pletschko & Verena Rosenmayr

Masterclasses in NF: Emotional Challenges in NF1, NF2 and Schwannomatosis

Susie Henley, DClinPsy, PhD, Guy’s and St Thomas’ NHS Foundation Trust, London UK

Thomas Pletschko, PhD, Medical University of Vienna, Austria

Verena Rosenmayr, Clinical Psychologist, Medical University of Vienna, Austria

Masterclasses in NF: NF1 Pediatric Management - Rianne Oostenbrink

Masterclasses in NF: NF1 Pediatric Management

Rianne Oostenbrink, MD, PhD, Erasmus University Medical Center, Rotterdam, Netherlands

Masterclasses in NF: Associated Glioma in Children - the Optic Pathway and Beyond - Amedeo Azizi

Masterclasses in NF: Associated Glioma in Children - the Optic Pathway and Beyond

Amedeo Azizi, MD, PhD, Head of the Paediatric Neurofibromatosis Program and Paediatric Neuro-Oncology Program, Medical University of Vienna, Austria

Masterclasses in NF: NF1 Orthopedic Manifestations - Eric Legius and Christophe Glorion

Masterclasses in NF: NF1 Orthopedic Manifestations

Eric Legius, MD, PhD. Head of Clinical Genetics Department of the University Hospital Leuven, Belgium

Christophe Glorion, MD, PhD, Department of Paediatric Orthopedic and Traumatologic Surgery, Hopital Necker-Enfants Malades, Paris, France. 

Masterclasses in NF: NF1 Malignant Peripheral Nerve Sheath Tumours - Rosalie Ferner and Viktor-Felix Mautner

Masterclasses in NF: NF1 Malignant Peripheral Nerve Sheath Tumours

Prof Rosalie Ferner, Consultant Neurologist and Lead Clinician for Neurofibromatosis, Guy's and St. Thomas' NHS Foundation Trust, London. Member of the MAB of Nerve Tumours UK and Trustee of Nerve Tumours UK

Viktor-Felix Mautner, MD, PhD. University Medical Centre in Hamburg-Eppendorf, Germany. Head of NF Outpatient Department

Masterclasses in NF - Neurofibromatosis Type 1: Cutaneous Neurofibromas - Pierre Wolkenstein and Sirkku Peltonen

Masterclasses in NF - Neurofibromatosis Type 1: Cutaneous Neurofibromas

Pierre Wolkenstein, MD, PhD. Hopital Henri-Mondor, Paris, France. Head of the Department of Dermatology

Sirkku Peltonen MD, PhD. University of Gothenberg, Sweden. Professor of Dermatology

INFER (International NF Educational Resources) is a series of online educational lectures for medical professionals by leading neurofibromatosis experts. The Masterclasses take place online approximately once a month, each on a different topic, and include real-time interaction between the expert presenter and the participants. The presentations are conducted in English, with real-time audio interpretation available in 6 additional languages: French, German, Italian, Portuguese, Russian, and Spanish. A recording of each INFER masterclass is then be made available online in each language for those who could not attend an event. INFER is an initiative of Children’s Tumor Foundation Europe, supported by an educational grant from AstraZeneca. https://ctfeurope.org/research/masterclasses-in-nf

BPNA Keynote Lecture - Prof Rosalie Ferner - Neurofibromatosis 1 in the 21st Century

‘Neurofibromatosis 1 in the 21st Century’

Keynote Lecture at the 48th British Paediatric Neurology Association Annual Scientific Meeting on 21st January 2022

Prof Rosalie Ferner, Consultant Neurologist and Lead Clinician for Neurofibromatosis, Guy's and St. Thomas' NHS Foundation Trust, London. Member of the MAB of Nerve Tumours UK and Trustee of Nerve Tumours UK